(AEMD)
NCM – Real Time Price. Currency in USD
2.15
-0.12 (-5.29%)
At close: Mar 27, 2026, 4:00 PM EDT
2.12
-0.03 (-1.40%)
After-hours: Mar 27, 2026, 6:36 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
2.15
-0.12 (-5.29%)
At close: Mar 27, 2026, 4:00 PM EDT
2.12
-0.03 (-1.40%)
After-hours: Mar 27, 2026, 6:36 PM EDT
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
| Name | Position |
|---|---|
| Dr. Steven P. LaRosa M.D. | Chief Medical Officer |
| Mr. James B. Frakes M.B.A. | CEO, CFO, Chief Accounting Officer, Secretary & Director |
| Ms. Michele Bombardiere | VP & Controller |
| Date | Type | Document |
|---|---|---|
| 2026-03-17 | 8-K | aethlon_8k.htm |
| 2026-01-26 | 8-K | aethlon_8k.htm |
| 2026-01-16 | DEF 14A | aethlon_idef14a.htm |
| 2026-01-07 | S-1 | aethlon_s1.htm |
| 2025-12-23 | D | |
| 2025-12-08 | 8-K | aethlon_8k.htm |
| 2025-11-12 | 10-Q | aethlon_i10q-093025.htm |
| 2025-11-06 | 8-K | aethlon_8k.htm |
| 2025-10-22 | 8-K | aethlon_8k.htm |
| 2025-10-16 | 8-K | aemd_8k.htm |